secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001193125-26-164018
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics regains full compliance with Nasdaq listing requirements; monitoring periods imposed
--------------------------------------------------------------------------------

- Nasdaq confirmed compliance with $2.5M stockholders' equity rule (Mar 9) and $1.00 bid price rule (Apr 17).
- One-year Mandatory Panel Monitor for both equity and bid price; failure during monitor triggers delist determination without cure period.
- Company remains listed on Nasdaq Capital Market under symbol FBLG; all prior listing matters closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526164018/0001193125-26-164018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526164018/fblg-20260309.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-164018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer